Efficacy and safety of intravenous esketamine in patients with treatment-resistant depression: A double-blind, double-randomization, placebocontrolled phase 2a study

Authors
Category Primary study
ConferenceNeuropsychopharmacology
Year 2013
This article has no abstract
Epistemonikos ID: a8d8b8bf7dfd37c9de186e1d16abdd8f07c85774
First added on: Apr 30, 2026